Convenience, satisfaction, health-related quality of life of once-weekly 70 mg/m2 vs. twice-weekly 27 mg/m2 carfilzomib (randomized A.R.R.O.W. study)
Philippe Moreau(Centre National de la Recherche Scientifique), Meletios Α. Dimopoulos(Korea University), Emre Yücel(Amgen (United States)), Hartmut Goldschmidt(Heidelberg University), Anita Zahlten‐Kumeli(Amgen (United States)), Shinsuke Iida(Nagoya City University Hospital), Sumeet Panjabi(Amgen (United States)), Andrew Trigg(Bayer (United Kingdom)), Kim Cocks(University of Leeds), Ralph V. Boccia(Center for Cancer and Blood Disorders), Shaji Kumar(Mayo Clinic)
Cited by 30
Related Papers
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k
Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Hematological findings and complications of <scp>COVID</scp>‐19
|American Journal of Hematology|2020|1.7k